Royalty Pharma Plc (RPRX)
64.76
+0.90
(+1.41%)
USD |
NASDAQ |
Oct 26, 16:00
64.88
+0.12
(+0.19%)
After-Hours: 17:46
Royalty Pharma Price : 64.76 for Oct. 26, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 63.50 | 63.97 | 63.01 | 63.86 | 4.016M |
| Oct 22, 2026 | 62.34 | 63.84 | 62.34 | 63.75 | 2.808M |
| Oct 21, 2026 | 62.10 | 62.90 | 62.00 | 62.15 | 2.742M |
| Oct 20, 2026 | 60.92 | 62.42 | 60.78 | 62.25 | 2.493M |
| Oct 19, 2026 | 60.54 | 61.12 | 60.04 | 60.27 | 2.813M |
| Oct 16, 2026 | 59.89 | 61.31 | 59.72 | 60.96 | 5.787M |
| Oct 15, 2026 | 59.75 | 60.41 | 59.50 | 59.62 | 3.407M |
| Oct 14, 2026 | 56.93 | 59.08 | 56.78 | 58.99 | 2.828M |
| Oct 13, 2026 | 57.70 | 57.97 | 56.42 | 56.57 | 3.582M |
| Oct 12, 2026 | 57.04 | 57.92 | 56.85 | 57.78 | 2.465M |
| Oct 09, 2026 | 56.03 | 57.08 | 55.72 | 56.93 | 2.882M |
| Oct 08, 2026 | 56.57 | 56.71 | 55.13 | 56.21 | 2.847M |
| Oct 07, 2026 | 56.60 | 57.16 | 56.40 | 56.76 | 3.671M |
| Oct 06, 2026 | 56.66 | 57.13 | 56.04 | 56.44 | 2.434M |
| Oct 05, 2026 | 57.10 | 57.25 | 56.00 | 56.66 | 3.958M |
| Oct 02, 2026 | 57.64 | 57.91 | 56.96 | 57.16 | 2.229M |
| Oct 01, 2026 | 58.36 | 58.40 | 57.22 | 57.63 | 3.245M |
| Sep 30, 2026 | 58.07 | 58.64 | 57.70 | 58.36 | 3.654M |
| Sep 29, 2026 | 58.19 | 58.48 | 57.51 | 58.22 | 2.885M |
| Sep 28, 2026 | 57.88 | 58.76 | 57.63 | 58.37 | 1.863M |
| Sep 25, 2026 | 58.50 | 58.50 | 57.68 | 58.21 | 1.870M |
| Sep 24, 2026 | 57.69 | 58.87 | 57.66 | 58.29 | 2.019M |
| Sep 23, 2026 | 58.52 | 59.02 | 57.63 | 57.65 | 2.804M |
| Sep 22, 2026 | 58.27 | 59.03 | 57.86 | 58.52 | 2.692M |
| Sep 21, 2026 | 58.56 | 59.06 | 57.82 | 58.44 | 3.232M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Merck & Co., Inc. | 140.60 |
| Johnson & Johnson | 266.50 |
| ANI Pharmaceuticals, Inc. | 71.93 |
| Corcept Therapeutics, Inc. | 87.23 |
| Veru, Inc. | 2.22 |
Price Related Metrics
| PE Ratio | 34.48 |
| PS Ratio | 13.42 |
| Price to Book Value | 4.225 |
| Price to Free Cash Flow | 55.56 |
| Earnings Yield | 2.90% |
| Market Cap | 28.87B |
| Operating PE Ratio | 21.53 |
| Normalized PE Ratio | 36.67 |